Why drug safety should not take a back seat to efficacy.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 21984875.
- Also identified by DOI 10.1371/journal.pmed.1001097 and PMC identifier 3181229.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The <i>PLoS Medicine</i> editors argue that methodological challenges in monitoring the safety of prescription medications should not mean that drug safety be considered less important than efficacy.
Medical subject headings
- Drug-Related Side Effects and Adverse Reactions
- Prescription Drugs